Vaptan drugs

by G Decaux 2024 Cited by 446of vaptan antagonist activity; whereas AVP contacts both the extracellular loops and residues in the interhelical pocket of AVPR2, the vaptans.

VAPTANS for Hyponatremia from @MedscapeKidney @Medscape Nephpearls

by N Gilles 2024MQ1 is the V2R antagonist with the largest therapeutic window in rodents, which is promising for the development of safer drugs than vaptans.

drugs under pre-clinical or clinical development or discontinued hydrochlorothiazide; torasemide; triamterene;; Vaptans, e.g.

Vasopressin receptor antagonists (vaptans) are a new class of drugs to treat congestive heart failure. Since there are three subtypes of the receptor locat.

Vasopressin receptor antagonists (Vaptans) are a new group of nonpeptide drugs which have been used in various clinical conditions with limited success. Whereas conivaptan is to be administered intravenously, the other vaptans like tolvaptan, lixivaptan, and satavaptan are effective as oral medication.

Vasopressin receptor antagonists (Vaptans) are a new group of nonpeptide drugs which have been used in various clinical conditions with limited success. Whereas conivaptan is to be administered intravenously, the other vaptans like tolvaptan, lixivaptan, and satavaptan are effective as oral medication.

Acetazolamide; amiloride; bumetanide; canrenone; chlortalidone hydrochlorothiazide; torasemide; triamterene;; Vaptans, e.g.

spironolactone; thiazides, e.g. bendroflumethiazide, chlorothiazide and hydrochlorothiazide; torasemide; triamterene;; Vaptans, e.g.